ALNYLAM PHARMACEUTICALS, INC. ALNY 49.92
Health Care · NASDAQ · Data as of 2026-10-29
ALNYLAM PHARMACEUTICALS, INC. (ALNY) has delivered +65.4% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #916 of 1968 stocks overall and #95 of 260 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
49.92
Overall Rank
#916 / 1968
Sector Rank
#95 / 260
Revenue CAGR
+65.4%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio